ALSPW Spineway SAS

ESP prostheses training program

ESP prostheses training program

Press release        Ecully, July 11, 2024 – 6.30 p.m.



Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in Strasbourg

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, organized a hands-on training workshop entitled “Hands-on Total Disc Replacement featuring ESP technology” at the Institut de Recherche contre les Cancers de l’Appareil Digestif (IRCAD) in Strasbourg on June 28, 2024. During the event, Spineway’s ESP prostheses (cervical and lumbar) were presented to 25 surgeons and professionals, with a presentation of the products, their indications and two surgical approach sessions.

The training workshops took place at IRCAD in Strasbourg, renowned for the quality of its facilities and were led by renowned surgeons, Dr. Biren Desai (Germany), Dr. Olivier Ricart (Luxembourg) and Pr. Marc Antoine Rousseau (Paris).

During these hands-on workshops, Spineway had three tables dedicated to training surgeons in total disc replacement, with its cervical (CP-ESP) and lumbar (LP-ESP) prostheses.

 

These training courses, highly appreciated by surgeons, allow professionals to study and practice different surgical approaches in order to learn or perfect their technique. The workshop was attended by nine international surgeons who were divided into groups of three on each table to ensure optimal training time for each participant. Participants came from Spain, Malaysia, Greece, the United Arab Emirates, Tunisia, France and Germany, reflecting the international scope of the event. Some were accompanied by their distributors, bringing the total number of participants to 25. Spineway teams were also present, including Stéphane Le Roux (CEO), Fabrice Paccagnella (Sales Director), Mélody Ourdouillié (Medical Education), Loïc Aden (Product Manager), Inès Khaoua and Yiyi Li (Sales).

The event was an opportunity to create or strengthen ties between new and future users of Spineway products and training surgeons, while supporting the Group’s distributors in their training initiatives.

In line with its strategy, Spineway aims to develop and reinforce the number of such training courses in order to strengthen its reputation among spine surgeons. The Group confirms its aim of becoming a major player in less invasive spine treatments.

Next event:

July 15, 2024 – H1 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of independent distributors and derives more than 70% of its revenue from exports.

ISIN: FR001400BVK2 – ALSPW        

Contacts:

SPINEWAY GROUP



Shareholder-services line



Available Tuesday through Thursday



+33 (0)806 706 060
Eligible PEA / PME





ALSPW





Euronext Growth

AELIUM



Finance & Ciommunication







Investor relations



Solène Kennis





Attachment



EN
11/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

Spineway : a week dedicated to medical excellence with more than 20 su...

Spineway : a week dedicated to medical excellence with more than 20 surgeons trained Press release         Ecully, November 14, 2024 – 6 p.m. Spineway: a week dedicated to medical excellence with more than 20 surgeons trained The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders, organized a week of training dedicated to medical education from November 4 to 8, 2024. Through practical sessions in the operating room and on anatomical specimens in the laboratory, this intensive program trained over 20 international surgeons in the use of the G...

 PRESS RELEASE

SPINEWAY : une semaine au service de l'Excellence Médicale avec plus d...

SPINEWAY : une semaine au service de l'Excellence Médicale avec plus de 20 chirurgiens formés Communiqué de presse          Ecully, le 14 novembre 2024 – 18h Spineway : une semaine au service de l'Excellence Médicale avec plus de 20 chirurgiens formés Le groupe Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), a organisé une semaine de formation dédiée à l’éducation médicale du 4 au 8 novembre 2024. À travers des sessions pratiques en bloc opératoire et sur pièces anatomiques en laboratoire, ce programme intensif a ...

 PRESS RELEASE

Spineway generates great interest at the EUROSPINE 2024 Congress in Vi...

Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna Press release       Ecully, October 22, 2024 – 6 p.m. Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, took part in the , Europe’s leading spine conference, held from October 2 to 4, in Vienna, Austria. During the event, which brought together more than 3,500 spine surgeons and professionals from all over the world, Spineway enjoyed a prime location in the heart of the Messe Wien congr...

 PRESS RELEASE

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 ...

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million (+21%) Press release         Ecully, October 15, 2024 – 6 p.m. SPINEWAY Continued organic growthNine-month 2024 revenue of €9.1 million (+21%) In thousands of euros20242023Change %Q1 revenue3,0702,39828%Q2 revenue3,4653,03314%Q3 revenue2,5752,07724%9M revenue9,1107,51021% Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an excellent third quarter in 2024, with revenue of €2.6 million, representing purely organic growth (...

 PRESS RELEASE

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à...

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) Communiqué de presse          Ecully, le 15 octobre 2024 –18h SPINEWAY Poursuite de la croissance organiqueChiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) En milliers d’euros20242023Variation en %CA 1er trimestre3 0702 398+ 28%CA 2ème trimestre3 4653 033+ 14%CA 3ème trimestre2 5752 077+ 24%CA 9 mois9 1107 510+ 21% Données consolidées non auditées Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), a réalisé un t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch